Form 4: Altimmune Chief Business Officer Acquires Shares Through Employee Stock Purchase Plan

Altimmune's Chief Business Officer, Raymond M Jordt, acquired 2,614 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $5.18 per share.

Summary

• Raymond M Jordt, Chief Business Officer of Altimmune, Inc., acquired 2,614 shares of common stock on January 31, 2025.
• The shares were purchased through the company's 2019 Employee Stock Purchase Plan (ESPP).
• The purchase price was $5.18 per share.
• The ESPP purchase period was from August 1, 2024, through January 31, 2025.
• The purchase price was based on 85% of the closing price of Altimmune's common stock on August 1, 2024.
• Following the transaction, Mr. Jordt directly owns 34,902 shares of Altimmune common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a positive but not extraordinary sentiment. The executive's participation in the ESPP is a positive sign of confidence.

Positives

• The purchase demonstrates the executive's confidence in the company's future prospects.
• The ESPP provides an opportunity for employees to invest in the company at a discounted price.

Industry Context

This is a routine transaction related to employee compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Employee stock purchase plans are a common benefit offered by publicly traded companies to align employee interests with shareholder value.
• The 15% discount offered through the ESPP is within the typical range for such plans.
• Similar transactions are regularly reported by executives at comparable biotech companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns management's interests with the company's performance.
• Employees benefit from the opportunity to purchase company stock at a discount.

Key Dates

Keywords

Altimmune, Employee Stock Purchase Plan, ESPP, insider trading, stock acquisition, Raymond M Jordt, Chief Business Officer